California State Teachers Retirement System Cuts Stock Position in Encompass Health Corporation $EHC

California State Teachers Retirement System lowered its stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 2.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 114,812 shares of the company's stock after selling 2,902 shares during the quarter. California State Teachers Retirement System owned about 0.12% of Encompass Health worth $11,605,197 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. BlackRock Inc. purchased a new position in Encompass Health during the second quarter worth about $1,059,762,000. Northwestern Mutual Wealth Management Co. boosted its stake in Encompass Health by 3,059,159.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company's stock worth $402,640,000 after purchasing an additional 3,793,358 shares during the period. Geode Capital Management LLC raised its stake in shares of Encompass Health by 7.6% in the 4th quarter. Geode Capital Management LLC now owns 1,946,134 shares of the company's stock valued at $206,605,000 after acquiring an additional 137,892 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Encompass Health by 3.1% during the first quarter. Dimensional Fund Advisors LP now owns 1,674,784 shares of the company's stock valued at $162,013,000 after purchasing an additional 50,647 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Encompass Health during the fourth quarter worth $133,221,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Trading Up 0.2%

NYSE:EHC traded up $0.27 during trading hours on Tuesday, hitting $122.80. 296,647 shares of the stock were exchanged, compared to its average volume of 1,043,549. The company's 50 day moving average is $117.45 and its two-hundred day moving average is $108.17. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $127.99. The company has a market capitalization of $12.11 billion, a P/E ratio of 20.01, a price-to-earnings-growth ratio of 2.46 and a beta of 0.75.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.48 by $0.07. The business had revenue of $1.60 billion for the quarter, compared to analysts' expectations of $1.57 billion. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The firm's quarterly revenue was up 9.6% compared to the same quarter last year. During the same period last year, the firm posted $1.40 earnings per share. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, sell-side analysts anticipate that Encompass Health Corporation will post 6.08 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be issued a $0.21 dividend. The ex-dividend date is Thursday, October 1st. This represents a $0.84 dividend on an annualized basis and a yield of 0.7%. This is an increase from Encompass Health's previous quarterly dividend of $0.19. Encompass Health's payout ratio is presently 13.68%.

Analyst Ratings Changes

A number of equities analysts have recently commented on EHC shares. Leerink Partners set a $152.00 price target on Encompass Health in a report on Friday, May 22nd. Barclays increased their price objective on shares of Encompass Health from $140.00 to $144.00 and gave the company an "overweight" rating in a research report on Thursday, August 6th. Truist Financial upped their target price on Encompass Health from $140.00 to $150.00 and gave the company a "buy" rating in a research note on Friday, August 7th. UBS Group lifted their price objective on Encompass Health from $150.00 to $155.00 and gave the company a "buy" rating in a research note on Friday, August 7th. Finally, Weiss Ratings raised shares of Encompass Health from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, August 12th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $146.83.

Insiders Place Their Bets

In other Encompass Health news, EVP John Darby sold 4,858 shares of the firm's stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $121.09, for a total value of $588,255.22. Following the completion of the sale, the executive vice president owned 75,041 shares of the company's stock, valued at approximately $9,086,714.69. This trade represents a 6.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Mark Tarr sold 173,148 shares of the firm's stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the sale, the chief executive officer owned 267,814 shares of the company's stock, valued at $33,602,622.58. This represents a 39.27% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 186,912 shares of company stock valued at $23,434,845 over the last three months. Insiders own 1.80% of the company's stock.

Encompass Health Profile

Encompass Health Corporation NYSE: EHC is a provider of post-acute healthcare services in the United States. The company operates inpatient rehabilitation hospitals that care for patients recovering from illness, injury, surgery or other medical conditions requiring intensive rehabilitation.

Its rehabilitation programs commonly serve patients recovering from strokes, brain and spinal cord injuries, neurological disorders, cardiac and pulmonary conditions, hip fractures, amputations and other orthopedic conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.